180 Life Sciences Corp
ATNF7.040USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
42.52MMarket Cap
LossP/E TTM
More Details of 180 Life Sciences Corp Company
180 Life Sciences Corp. is focused on developing new technologies across multiple sectors. The Company is focused on iGaming sector, through its iGaming Technology Platform. The Company also continues to evaluate monetization strategies for its biotechnology assets.
180 Life Sciences Corp Info
Ticker SymbolATNF
Company name180 Life Sciences Corp
IPO dateJun 07, 2017
CEOMr. Blair Jordan
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJun 07
Address3000 El Camino Real
CityPALO ALTO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code94306
Phone16505070669
Websitehttps://180lifesciences.com/
Ticker SymbolATNF
IPO dateJun 07, 2017
CEOMr. Blair Jordan
Company Executives of 180 Life Sciences Corp
Name
Name/Position
Position
Shareholding
Change
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
688.16K
+12058.30%
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
428.70K
-3.75%
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
324.87K
--
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. Jason G. New
Mr. Jason G. New
Director
Director
--
--
Ms. Crystal Heter
Ms. Crystal Heter
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
688.16K
+12058.30%
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
428.70K
-3.75%
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
324.87K
--
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. Jason G. New
Mr. Jason G. New
Director
Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 18
Updated: Thu, Dec 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cyber Citadel
8.63%
Electric Capital Partners, LLC
7.98%
Pemble (Brian James)
7.74%
Zippy, Inc
7.74%
FF Consumer Growth II, LP
5.39%
Other
62.52%
Shareholders
Shareholders
Proportion
Cyber Citadel
8.63%
Electric Capital Partners, LLC
7.98%
Pemble (Brian James)
7.74%
Zippy, Inc
7.74%
FF Consumer Growth II, LP
5.39%
Other
62.52%
Shareholder Types
Shareholders
Proportion
Corporation
30.52%
Individual Investor
20.73%
Hedge Fund
11.14%
Investment Advisor
6.92%
Investment Advisor/Hedge Fund
2.51%
Venture Capital
1.28%
Research Firm
0.96%
Pension Fund
0.10%
Other
25.84%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
49
2.39M
14.13%
+2.27M
2025Q2
52
4.40M
43.09%
+1.20M
2025Q1
53
1.98M
52.21%
+1.28M
2024Q4
50
767.05K
24.14%
+685.05K
2024Q3
50
163.68K
7.41%
+97.43K
2024Q2
54
35.70K
4.43%
-40.39K
2024Q1
61
51.17K
6.90%
-21.55K
2023Q4
66
65.60K
11.28%
+5.63K
2023Q3
73
63.54K
20.50%
+26.66K
2023Q2
76
29.62K
13.63%
-18.64K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
FF Consumer Growth II, LP
11.59M
7.24%
+11.59M
--
Aug 04, 2025
Citadel Advisors LLC
8.42M
5.26%
+8.42M
--
Sep 25, 2025
Steadfast Capital Management LP
11.32M
7.07%
+11.32M
--
Aug 04, 2025
Rudisill (McAndrew)
6.33M
3.95%
+6.33M
--
Aug 20, 2025
Smith (Ryan Lewis)
167.18K
0.1%
--
--
Aug 20, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Schwab U.S. Small-Cap ETF
0.01%
Schwab U.S. Broad Market ETF
0%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Schwab U.S. Broad Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 26, 2024
Merger
19→1
Feb 26, 2024
Merger
19→1
Feb 26, 2024
Merger
19→1
Feb 26, 2024
Merger
19→1
Dec 16, 2022
Merger
20→1
Dec 16, 2022
Merger
20→1
Date
Type
Ratio
Feb 26, 2024
Merger
19→1
Feb 26, 2024
Merger
19→1
Feb 26, 2024
Merger
19→1
Feb 26, 2024
Merger
19→1
Dec 16, 2022
Merger
20→1
Dec 16, 2022
Merger
20→1
Dec 16, 2022
Merger
20→1
Dec 16, 2022
Merger
20→1
FAQs
Who are the top five shareholders of 180 Life Sciences Corp?
The top five shareholders of 180 Life Sciences Corp are:
FF Consumer Growth II, LP holds 11.59M shares, accounting for 7.24% of the total shares.
Citadel Advisors LLC holds 8.42M shares, accounting for 5.26% of the total shares.
Steadfast Capital Management LP holds 11.32M shares, accounting for 7.07% of the total shares.
Rudisill (McAndrew) holds 6.33M shares, accounting for 3.95% of the total shares.
Smith (Ryan Lewis) holds 167.18K shares, accounting for 0.10% of the total shares.
FF Consumer Growth II, LP holds 11.59M shares, accounting for 7.24% of the total shares.
Citadel Advisors LLC holds 8.42M shares, accounting for 5.26% of the total shares.
Steadfast Capital Management LP holds 11.32M shares, accounting for 7.07% of the total shares.
Rudisill (McAndrew) holds 6.33M shares, accounting for 3.95% of the total shares.
Smith (Ryan Lewis) holds 167.18K shares, accounting for 0.10% of the total shares.
What are the top three shareholder types of 180 Life Sciences Corp?
The top three shareholder types of 180 Life Sciences Corp are:
Cyber Citadel
Electric Capital Partners, LLC
Pemble (Brian James)
Cyber Citadel
Electric Capital Partners, LLC
Pemble (Brian James)
How many institutions hold shares of 180 Life Sciences Corp (ATNF)?
As of 2025Q3, 49 institutions hold shares of 180 Life Sciences Corp, with a combined market value of approximately 2.39M, accounting for 14.13% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -28.96%.
What is the biggest source of revenue for 180 Life Sciences Corp?
In --, the -- business generated the highest revenue for 180 Life Sciences Corp, amounting to -- and accounting for --% of total revenue.
